Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2003
09/23/2003US6624169 Urokinase inhibitors
09/23/2003US6624168 Bactericides, bacteriostats
09/23/2003US6624167 Compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and disorders associated with dysfunction of the central and autonomic nervous systems can
09/23/2003US6624166 Pharmaceutical compositions containing the compounds; and a method for inhibiting interleukin-1 beta protease activity in a mammal utilizing the compounds and compositions for enzyme inhibitors
09/23/2003US6624164 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
09/23/2003US6624163 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and Attention Deficit Hyperactivity Disorder
09/23/2003US6624161 Administering 2-oxy substituted benzoxazin-5-one derivative to a human or animal for the prevention or treatment of obesity or an obesity related disorder
09/23/2003US6624160 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
09/23/2003US6624159 Herpes virus
09/23/2003US6624157 Antitumor agents
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6624150 Method of treating gastrointestinal tract disease with purinergic receptor agonists
09/23/2003US6624148 Synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biomolecules from the activated mast cells, composed of
09/23/2003US6624142 Trimethyl lock based tetrapartate prodrugs
09/23/2003US6623962 Enzymatic nucleic acid treatment of diseases of conditions related to levels of epidermal growth factor receptors
09/23/2003US6623763 Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism
09/23/2003US6623761 Emulsion; therapy, diagnosis
09/23/2003US6623760 Micronization with intermittent curing crystallization; controlled particle size distribution and amorphous content materials
09/23/2003US6623759 A core which contains an active selected from Omeprazole, Lansoprazole and Pantoprazole, together with adjuvants, an intermediate reactive layer applied on the core, a gastric juice resistant alkali neutralized polymeric outer layer
09/23/2003US6623758 Controlled release synergistic treatment of bacterial infections
09/23/2003US6623757 Mixture of antibiotics; variations of releasing profiles
09/23/2003US6623755 Pharmaceutical tablets
09/23/2003US6623753 Allylamine-containing liposomes
09/23/2003US6623752 Polyacrylate matrix containing vitamin E component permeation promoter
09/23/2003US6623744 For hand preparation such as a lotion or as a presurgical scrub replacement
09/23/2003US6623734 Super absorption coenzyme Q10
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/23/2003US6623730 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
09/23/2003US6623729 Process for preparing sustained release micelle employing conjugate of anticancer drug and biodegradable polymer
09/23/2003US6623724 Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues
09/23/2003US6623723 Method for treating bronchial constriction and bronchospasm
09/23/2003CA2301019C Anti-bacterial/anti-viral coatings, coating process and parameters thereof
09/23/2003CA2295992C Method for preparing a substituted perhydroisoindole
09/23/2003CA2285005C Sequential release throat drops for relief of cough and cold
09/23/2003CA2275527C Novel heterocyclic substituted pyrrolidine amide derivatives
09/23/2003CA2268927C Aqueous-based pharmaceutical composition
09/23/2003CA2244196C Dihydrobenzofuran compounds useful as anti-inflammatory agents
09/23/2003CA2218555C Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
09/23/2003CA2210351C Method of treating chronic progressive vascular diseases
09/23/2003CA2141703C Mouthwash
09/23/2003CA2139781C Ophthalmic topical composition containing (s)-timolol hemihydrate
09/23/2003CA2115442C Pharmaceutical preparation containing an uricosuric agent and an excitatory amino acid antagonist
09/23/2003CA2106371C Process for the preparation of ergoline derivatives
09/23/2003CA2101332C Antibody polycation conjugates
09/23/2003CA2098122C Anti-atherosclerotic aryl compounds
09/23/2003CA2091651C Agent for suppresion and interception of mailard reaction
09/23/2003CA2086654C Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them
09/23/2003CA2074385C Pleuromutilin complexes
09/23/2003CA2073760C Steroidal organic substance crystallization method and compounds thereby obtained
09/23/2003CA2073633C Use of xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas
09/23/2003CA2072814C Benzomorphans and their use as pharmaceutical compositions
09/23/2003CA2066807C Contraception in female primates without affecting the menstrual cycle
09/23/2003CA2062973C Combination therapy for prophylaxsis and/or treatment of benign prostatic hyperplasia
09/21/2003CA2422623A1 Microdialysis methods and applications for treatment and/or prophylaxis of tumors and/or infections in the central nervous system (cns) and/or in other parenchymal organs
09/20/2003CA2377608A1 Tet-transactivator system
09/19/2003WO2002072077A2 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
09/19/2003CA2457192A1 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
09/18/2003WO2003076617A1 Transporter selectively transporting sulfate conjugate and its gene
09/18/2003WO2003076602A2 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
09/18/2003WO2003076594A2 Genomic screen for epigenetically silenced tumor suppressor genes
09/18/2003WO2003076593A2 Genomic screen for epigenetically silenced genes associated with cancer
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076490A1 Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound
09/18/2003WO2003076475A1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
09/18/2003WO2003076457A1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME
09/18/2003WO2003076447A1 An optically acitve pyridine derivative and a medicament containing the same
09/18/2003WO2003076446A1 Antiparasitic artemisinin derivatives (endoperoxides)
09/18/2003WO2003076445A2 Microtubule stabilizing compounds
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076442A1 Purine derivatives as kinase inhibitors
09/18/2003WO2003076441A1 Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
09/18/2003WO2003076440A1 Condensed heterocyclic compounds as calcitonin agonists
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076437A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076435A1 Pyrimidine compounds
09/18/2003WO2003076434A1 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
09/18/2003WO2003076433A1 Pyrimidine compounds
09/18/2003WO2003076432A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
09/18/2003WO2003076431A1 Benzimidazole-derivatives for the treatment of sexual dysfunction
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076429A2 Azepane derivatives and their use as atk1 inhibitors
09/18/2003WO2003076427A1 Quinazoline compounds useful in therapy
09/18/2003WO2003076425A1 Novel compounds and antimalarials
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076420A1 Cyclic amides
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003076414A2 Aryl substituted pyrimidines and the use thereof
09/18/2003WO2003076413A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
09/18/2003WO2003076412A1 Novel hairpin polyamide
09/18/2003WO2003076411A1 Process for producing optically active sulfoxide derivative
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076405A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003WO2003076404A1 Chain oligolactic acid thioester
09/18/2003WO2003076402A1 Therapeutic agent for pain
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
1 ... 5335 5336 5337 5338 5339 5340 5341 5342 5343 5344 5345 5346 5347 5348 5349 5350 5351 5352 5353 5354 5355 ... 7860